Company Overview
Company Type: Private Company
Website: www.cedarlanelabs.com
Number of Employees: 80
Year Founded: 1957
Total Amount Raised (CAD mm)†: -
Total Rounds of Funding**:-
Latest Post-Money Valuation ($ mm) -
Latest Pre-Money Valuation ($ mm) -
† This number reflects the estimated value of the total new money raised through private placement rounds.
** This value is an estimate of the total number of funding rounds this company has received.


Business Description
Cedarlane Corporation manufactures and distributes research reagents for the life science community. It offers reagents; biological tools, such as mouse and rat hypothalamic cell lines for basic science, drug discovery, and therapeutic development applications; clinical and diagnostic products; and engineered climate control products for storage and transportation of perishable and time sensitive goods. The company also provides monoclonal antibodies, polyclonal antibodies, cell separation media, complement for tissue typing, and immunocolumns. In addition, it offers custom antibody services, including peptide antigen design and synthesis, protein expression in E. Coli system and purification, polyclonal antibody production, monoclonal antibody production, low endotoxin antibody production and purification, antibody purification, custom conjugations, lyophilization/freeze-drying, custom microtiter plate coating, and testing services. Further, the company provides cryo-protection products, gel packs-refrigerants, insulated shipping containers, pre-qualified solutions, temperature indicators, and other shipping supplies products. It offers its products through a network of distributors worldwide. Cedarlane Corporation was founded in 1957 and is based in Burlington, Canada.


Financial Information (Currency: CAD, in mm)
Total Revenue
 30.4
Operating Income
-
Total Assets
-
Gross Profit
-
EBITDA
-
Total Debt
-
Net Income
-
Estimated Number of Employees
 80
Net Debt
-
* Hover over data point numbers for date and source.

Key Professionals
Name
Title
Greer, Cynthia N.
President


Primary Industry Classification
Life Sciences Tools and Services


Primary Office Location
4410 Paletta Court | Burlington, ON | L7L 5R2 | Canada
Phone: 289-288-0001   Fax: 289-288-0020

Current and Pending Investors
Investor
Initial Investment Date
Stake Type
Current Stake Amount
Round(s)
SilverMill, LLC
-
Majority
-
-


Company Notes
No Company Notes exist.


Strategy Notes
No Strategy Notes exist.


Last 5 Key Developments
Date
Event Type
Headline
Dec-21-2021
Lawsuits & Legal Issues
ExCellThera Inc. Announces Settlement of Its Patent Infringement Claims Against Selleck Chemicals
May-18-2021
Client Announcements
Bay Area Health Trust Announces Availability of McMaster Molecular Medium from Cedarlane Corporation
May-16-2017
Client Announcements
Canon Biomedical Announce the Launch of Novallele Genotyping Products in Canada for Sale Through Cedarlane Corporation
Dec-13-2010
Client Announcements
TGR Biosciences Pty Ltd. and Cedarlane Corp. Announces Distribution Partnership
Sep-08-2010
Client Announcements
Cellectis Bioresearch SAS and Cedarlane Corp. to Form Partnership for the Distribution of Cellectis Bioresearch's Research Kits in Canada


Last 10 Investment Research Documents
Contributor
Analyst
Date/Time
Company
Headline
Type
Pages
GlobalData

Sep 19, 2023 05:11 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Jun 21, 2023 03:00 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Mar 22, 2023 01:42 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Dec 25, 2022 11:47 PM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Sep 30, 2022 12:40 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Jun 23, 2022 11:36 PM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Mar 28, 2022 01:36 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
15
GlobalData

Dec 22, 2021 02:03 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
14
GlobalData

Sep 21, 2021 06:17 AM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
10
GlobalData

Jun 23, 2021 07:53 PM
Cedarlane Corporation
Cedarlane Laboratories Ltd
Reports
10


S&P Global Ratings Credit Ratings
No S&P Global Ratings Credit Ratings data available. 


News Headlines
No News is currently available for the selected sources.


Company Coverage
This company is not on any Coverage List.

Key Executives and Professionals Details
Name
Title
Phone
Fax
Email
Greer, Cynthia N.
President
289-288-0001
289-288-0020
-
* denotes that the relationship is proprietary

S&P Credit Ratings and Research provided by 
No content (including ratings, credit-related analyses and data, valuations, model, software or other application or output therefrom) or any part thereof (Content) may be modified, reverse engineered, reproduced or distributed in any form by any means, or stored in a database or retrieval system, without the prior written permission of S&P Global Market Intelligence or its affiliates (collectively, S&P Global). The Content shall not be used for any unlawful or unauthorized purposes. S&P Global and any third-party providers, as well as their directors, officers, shareholders, employees or agents (collectively S&P Global Parties) do not guarantee the accuracy, completeness, timeliness or availability of the Content. S&P Global Parties are not responsible for any errors or omissions (negligent or otherwise), regardless of the cause, for the results obtained from the use of the Content, or for the security or maintenance of any data input by the user. The Content is provided on an "as is" basis. S&P GLOBAL PARTIES DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE, FREEDOM FROM BUGS, SOFTWARE ERRORS OR DEFECTS, THAT THE CONTENT’S FUNCTIONING WILL BE UNINTERRUPTED OR THAT THE CONTENT WILL OPERATE WITH ANY SOFTWARE OR HARDWARE CONFIGURATION. In no event shall S&P Global Parties be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs or losses caused by negligence) in connection with any use of the Content even if advised of the possibility of such damages.

Credit-related and other analyses, including ratings, and statements in the Content are statements of opinion as of the date they are expressed and not statements of fact. S&P Global Market Intelligence’s opinions, analyses and rating acknowledgment decisions (described below) are not recommendations to purchase, hold, or sell any securities or to make any investment decisions, and do not address the suitability of any security. S&P Global Market Intelligence assumes no obligation to update the Content following publication in any form or format. The Content should not be relied on and is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment and other business decisions. S&P Global Market Intelligence does not act as a fiduciary or an investment advisor except where registered as such. While S&P Global Market Intelligence has obtained information from sources it believes to be reliable, S&P Global Market Intelligence does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives.

S&P Global keeps certain activities of its divisions separate from each other in order to preserve the independence and objectivity of their respective activities. As a result, certain divisions of S&P Global may have information that is not available to other S&P Global divisions. S&P Global has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process.

S&P Global Ratings does not contribute to or participate in the creation of credit scores generated by S&P Global Market Intelligence. Lowercase nomenclature is used to differentiate S&P Global Market Intelligence PD credit model scores from the credit ratings issued by S&P Global Ratings.

S&P Global may receive compensation for its ratings and certain analyses, normally from issuers or underwriters of securities or from obligors. S&P Global reserves the right to disseminate its opinions and analyses. S&P Global's public ratings and analyses are made available on its Web sites, www.standardandpoors.com (free of charge), and www.capitaliq.com (subscription), and may be distributed through other means, including via S&P Global publications and third-party redistributors. Additional information about our ratings fees is available at www.standardandpoors.com/usratingsfees.
Regulatory News Service data provided by 
